Prabahar Kousalya, Albalawi Maymonah Abdullah, Almani Lama, Alenizy Sarah
Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
J Res Pharm Pract. 2021 Jan 11;9(4):196-201. doi: 10.4103/jrpp.JRPP_20_97. eCollection 2020 Oct-Dec.
Uncontrolled chronic diseases such as hypertension and diabetes mellitus can lead to severe complications. Poor adherence to medication is one of the important reasons, leading to complications for chronically diseased patients. We aimed to assess the trend toward medication adherence and the reasons for medication nonadherence in chronic disease patients in Tabuk city in Saudi Arabia.
A cross-sectional study was conducted at a tertiary care hospital in Tabuk, Saudi Arabia. Participants were selected and interviewed for information regarding their medication adherence. A medication adherence rating scale questionnaire was used to measure the level of adherence in study participants. The data were analyzed by the statistical package for the social sciences (SPSS) database 24.
Overall, 208 participants were involved in this study. Among these, 134 (64.4%) were female, and 74 (35.6%) were male. This study showed that 159 (76.44%) participants were adherent to their medications and nearly one-quarter of patients were nonadherent to their medications. No statistically significant differences were found between male and female patients toward their medication adherence. The primary intentional and nonintentional reason for nonadherence was side effects and forgetfulness, respectively.
Tailoring the therapy according to the individual need of the patients will maximize the patient's adherence toward medications.
高血压和糖尿病等未得到控制的慢性病会导致严重并发症。药物依从性差是重要原因之一,会导致慢性病患者出现并发症。我们旨在评估沙特阿拉伯塔布克市慢性病患者的药物依从性趋势以及药物不依从的原因。
在沙特阿拉伯塔布克的一家三级护理医院进行了一项横断面研究。选择参与者并就其药物依从性信息进行访谈。使用药物依从性评分量表问卷来衡量研究参与者的依从水平。数据通过社会科学统计软件包(SPSS)数据库24进行分析。
总体而言,208名参与者参与了本研究。其中,134名(64.4%)为女性,74名(35.6%)为男性。本研究表明,159名(76.44%)参与者坚持服药,近四分之一的患者不坚持服药。男性和女性患者在药物依从性方面未发现统计学上的显著差异。不依从的主要有意和无意原因分别是副作用和遗忘。
根据患者的个体需求调整治疗将使患者对药物的依从性最大化。